Macrophage Polarization States in the Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Abstract
The M1/M2 macrophage paradigm plays a key role in tumor progression. M1 macrophages are historically regarded as anti-tumor, while M2-polarized macrophages, commonly deemed tumor-associated macrophages (TAMs), are contributors to many pro-tumorigenic outcomes in cancer through angiogenic and lymphangiogenic regulation, immune suppression, hypoxia induction, tumor cell proliferation, and metastasis. The tumor microenvironment (TME) can influence macrophage recruitment and polarization, giving way to these pro-tumorigenic outcomes. Investigating TME-induced macrophage polarization is critical for further understanding of TAM-related pro-tumor outcomes and potential development of new therapeutic approaches. This review explores the current understanding of TME-induced macrophage polarization and the role of M2-polarized macrophages in promoting tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that MSCs have the ability to polarize M1 pro-inflammatory macrophages towards an alternative M2 anti-inflammatory phenotype [21,22,23].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 3×
“These CD8+ T and NK cells express high levels of cytokines such as IFN-γ, GM-CSF, and TNF-α as well as chemokines such as CCL4, CCL5, and CCL23 that assist in the further recruitment of immune cells and the signaling of anti-tumorigenic pathways [73,74].”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 2×
“MDSCs express high levels of both iNOS and arginase-1, which both play a direct role in suppression of T-cell function [95].”
BackgroundOrigin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“Inflammation can be triggered by conditions such as infection or injury or can be systemic as seen in type 2 diabetes and cardiovascular disease [59].”
BackgroundMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 3×
“Current literature supports the theory that most TAMs originate from either tissueresident embryonic macrophages or macrophages derived from circulating monocytes that originate in the bone marrow [87].”
BackgroundMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 3×
“The significance of macrophage heterogeneity has been under review since the early 2000s and has been linked to many malignancies and autoimmune disorders in recent years [66].”
BackgroundProtective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“The resolution of inflammation is led by the deactivation of these inflammatory mediators, permitting either the apoptosis of pro-inflammatory M1 macrophages or the transition to an anti-inflammatory M2 macrophage [64].”
BackgroundMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 15×
“Macrophages are found in every human tissue in the body and exhibit anatomical and functional diversity [4].”
BackgroundInfluentialMurray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981 · cited 2×
“Some noncytokine, extrinsic pathways of macrophage polarization do exist, however, including hypoxia as well as the production of lactate within tumors, which drive M2 polarization [36].”
BackgroundFibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Cited by
Items 701–800 of 1,000
Yang, G., Yoon, S., Lee, J., Leem, S., & Choi, Y. H. (2025) · Genes & Genomics · doi:10.1007/s13258-025-01710-2 · Cited by 14
“As a result, the efficacy of ICIs is re - duced, as M2 macrophages actively suppress T cell activation and promote tumor immune evasion (Boutilier and Elsawa 2021; Ma et al. 2024; Martínez et al. 2017).”
NSUN2-mediated m5C modification of SOCS3 mRNA modulates macrophage polarization in bladder cancer
Tang, Y., Deng, X., Wang, Y., Zhou, Q., Zhang, C., Liu, Z., Zheng, R., Zeng, J., Tan, X., Wu, Z., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08306-4 · Cited by 10
Cogels, M., Caluwé, A. D., Buisseret, L., & Penninckx, S. (2026) · OncoImmunology · doi:10.1080/2162402x.2025.2608436 · Cited by 9
“98 In patients with poorly infiltrated tumors, LDRT increased T cell levels, in particular CD4 + T helper (Th) 1 cells in responders, while protumor macrophages and neutrophils were increased in non-responders.”
Engineered Bacterial Biomaterials for Augmenting Adoptive Immune Cell Therapy Against Solid Tumors
Zhu, C., Sun, Z., Wu, Q., Wang, F., Zhang, L. L., Wang, W., Ding, Y., & Li, H. (2026) · Advanced Materials · doi:10.1002/adma.202522140 · Cited by 11
Chabeli, M. S., Wang, X., Liang, Y., Chen, C., Yang, C., Shou, Y., Wang, S., & Chen, K. (2022) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2022.100621 · Cited by 10
Targhazeh, N., Hutt, K. J., Winship, A., Reiter, R. J., & Yousefi, B. (2022) · Biochimie · doi:10.1016/j.biochi.2022.09.010 · Cited by 10
Zhang, Z., Wen, C., Jia, M., Zhang, H., & Sun, S. (2022) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12617 · Cited by 9
“Drugs regulate cell growth, tissue repair, apoptosis, and inflammatory responses by regulating M1 or M2 polarization.(14) The study of alkannin-induced macrophage polarization”
BackgroundRen, C., Wang, Q., Xu, Z., Pan, Y., Li, Y., & Liu, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05352-3 · Cited by 11
“M1 macrophages are considered anti-tumor, whereas M2 macrophages are commonly regarded as TAMs with tumorigenic effects (Boutilier and Elsawa 2021).”
BackgroundZhi, W., Wang, Y., Jiang, C., Gong, Y., Chen, Q., Mao, X., Deng, W., & Zhao, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128244 · Cited by 9
“Previous studies have shown that macrophage polarization from the type M1 to M2 promotes tumorigenesis in various cancers (45).”
BackgroundHuang, M., Xia, Y., Li, K., Shao, F., Feng, Z., Li, T., Azin, M., & Demehri, S. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166494 · Cited by 12
“TAMs can express a combination of M1 and M2 markers, and their polarization is a dynamic process within the TME rather than commonly perceived M2 polarization (35).”
BackgroundLi, C., Wang, L., Li, Z., Li, Z., Zhang, K., Cao, L., Wang, Z., Shen, C., & Chen, L. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123729 · Cited by 9
Čunderlíková, B., Klučková, K., Babál, P., Mlkvý, P., & Teplický, T. (2024) · International Journal of Radiation Biology · doi:10.1080/09553002.2024.2310002 · Cited by 10
“Macrophages, however, may accomplish contra-dictory roles, depending on microenvironmental factors, including DAMPs (Serbulea et al. 2018; Boutilier and Elsawa 2021).”
BackgroundReichardt, C. M., Muñoz‐Becerra, M., Rigau, A. R., Rückert, M., Fietkau, R., Schett, G. A., Gaipl, U. S., Frey, B., & Munoz, L. E. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03653-1 · Cited by 9
“Another very popular example is macrophages that can be polarized into M1 and M2 macrophages by the TME [10].”
BackgroundLei, H., Xiang, T., Zhu, H., & Hu, X. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2903129 · Cited by 12
“…as anti-tumor, while M2-polarized macrophages, commonly deemed tumor-associated macrophages (TAMs), are contributors to many pro-tumorigenic outcomes in cancer through angiogenic and lymphangiogenic regulation, immune suppression, hypoxia induction, tumor cell proliferation, and metastasis [51].”
BackgroundSong, Y., Luo, X., Yao, L., Chen, Y., & Mao, X. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04193-x · Cited by 9
“Microglia can be categorized into classical (M1) and alternative (M2) types despite there is a spectrum of different intermediate phenotypes between M1 and M2, and microglia can transit from one phenotype to another [11, 12 ].”
Recombinant Human IL-32θ Induces Polarization Into M1-like Macrophage in Human Monocytic Cells
Park, H., Park, J., Kim, N., Kim, H., Kim, H.-G., Son, D. J., Hong, J. T., & Yoon, D. (2024) · Immune Network · doi:10.4110/in.2024.24.e27 · Cited by 9
“For example, M1 macrophages induce inflammation to eliminate infectious agents and neoplasms formed in tissues (34).”
BackgroundPiao, Y. J., Kim, H. S., Kim, H., Shen, J., & Moon, W. K. (2024) · BMC Cancer · doi:10.1186/s12885-024-12473-6 · Cited by 9
“7, there are potential caveats such as a species mismatch between the cell lines and discrepancies in M1 and M2 polarization markers between human and mouse macrophages [28].”
BackgroundFu, D., Shi, X., Yi, X., Wu, D., He, H., Zhou, W., & Cheng, W. (2024) · BMC Urology · doi:10.1186/s12894-024-01534-4 · Cited by 9
Liu, Y., Dong, M., Jia, Y., Yang, D., Yang, X., & Yang, X. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155544 · Cited by 11
Sun, X., Wang, C., Cao, J., Li, J., Ma, G., Wu, X., Sun, P., Wang, Y., Huang, J., Gale, R. P., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.08.023 · Cited by 9
Dai, Q., Peng, Y., He, P., & Wu, X. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2418344 · Cited by 9
“…of macrophages into M1 or M2 phenotypes is influenced by various molecules and signalling pathways. the intricate network of cytokines, chemokines, and growth factors produced by cancer cells, stromal cells, and immune cells creates a dynamic milieu that can affect macrophage polarisation [104].”
Lepik, K. V., & Витальевич, М. В. (2025) · Cancers · doi:10.3390/cancers17020317 · Cited by 10
Role of noncoding RNA and protein interaction in pancreatic cancer
Li, Z., Zhang, T., Xiao-juan, Y., & Peng, Y. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003587 · Cited by 9
“[149] Disruption of the balance between M1 and M2 macrophage polarization can contribute to PDAC progression.”
Cai, C., Zhang, Q., Ye, J., Yao, S., Li, Q., Fan, Z., Ge, S., Wang, Y., Xu, D., Zhou, J., et al. (2025) · Biomaterials Science · doi:10.1039/d5bm00202h · Cited by 9
Kang, Y., Lv, R., Feng, Z., & Zhu, J. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110430 · Cited by 10
Zhang, G., Dong, K., Liu, J., & Zhou, W. (2022) · Medicine · doi:10.1097/md.0000000000030927 · Cited by 9
“M1 and M2 macrophages are one of the major tumor-infiltrating immune cell types, the former typically exerting antitumor effects, including direct-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity killing tumor cells; while M2-polarized macrophages, generally considered tumor-associated macrophag…”
BackgroundPark, S. H., Eun, R., Heo, J., & Lim, Y. T. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01282-8 · Cited by 11
“Not only removal can be done, but conversion of M2 macrophages into M1 types by hydrogel containing TLR7/8a with nanoscale modulation for controlled release, or cell surface engineering via backpacking IFN-γ onto M1 macrophages has been shown to further enhance therapeutic efficacy, as reduction of M2 and expansion of…”
BackgroundGuan, Y., Xu, B., Sui, Y., Li, H., Chen, Z., Luan, Y., Yang, R., Qi, W., & Guan, Q. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02104-3 · Cited by 9
“The macrophage population consists of several subpopulations, including M0 macrophages, M1 macrophages, and M2 macrophages (Wu et al. 2020; Pan et al. 2020; Boutilier and Elsawa 2021).”
BackgroundMacrophage – tumor cell interaction beyond cytokines
Kovaleva, O. V., Sorokin, M., Egorova, A., Petrenko, A., Shelekhova, K. V., & Gratchev, A. N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1078029 · Cited by 10
“For the early stages, M1 macrophages are the predominant population, with tumor development the ratio shifts towards M2 (7, 8).”
BackgroundPRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
Wang, Q., Wang, X., Li, J., Yin, T., Wang, Y., & Cheng, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-52153-w · Cited by 9
“Macrophages originating in monocytes have two different activated states that play opposite roles in tumor immunity 53,54 .”
HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer
Ramos-Solís, N., Cannon, A., Dilday, T., Abt, M. A., Oblak, A. L., Soloff, A. C., Kaplan, M. H., & Yeh, E. S. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2364382 · Cited by 9
“19 In contrast, M2 TAMs, typically identified by surface markers such as CD206 and Arg1, share similar functions in both species and exhibit pro-tumoral and immunosuppressive functions.”
BackgroundMao, Y., Hu, Z., Xu, X., Xu, J., Wu, C., Jiang, F., & Zhou, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.973319 · Cited by 9
“Macrophages could support the progression and tumor drug resistance by providing nutritional support (Vitale et al., 2019; Boutilier and Elsawa, 2021).”
BackgroundBernstein, M. N., Scott, D., Hession, C. C., Nieuwenhuis, T. O., Gerritsen, J. S., Tabrizi, S., Nandivada, V., Huggins, M. A., Duan, M., Malu, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.14.557736 · Cited by 9
Understanding the Dual Role of Macrophages in Tumor Growth and Therapy: A Mechanistic Review
Summer, M., Riaz, S., Ali, S., Noor, Q., Ashraf, R., & Khan, R. R. M. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402976 · Cited by 10
Myeloid cells are involved in tumor immunity, metastasis and metabolism in tumor microenvironment
Zhang, C., Song, Y., Yang, H., & Wu, K. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10012-y · Cited by 9
“They can also directly interact with myeloid suppressor cells (MDSC) and inhibit T-cell-mediated anti-tumor response (Boutilier and Elsawa 2021).”
Zhang, T., Adams, C., Fejér, G., Ercolano, E., Cutajar, J., Na, J., Sahm, F., & Hanemann, C. O. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03419-2 · Cited by 8
“Macrophage activation exists along a dynamic continuum, with overlapping transcriptional and functional profiles influenced by various cytokines, metabolic cues, and spatial context within the TME [69].”
Liu, Y., Zhang, L., Wang, J., Xu, J., Xu, J., Xie, M., & Wang, R. (2025) · Cancer Biology & Therapy · doi:10.1080/15384047.2025.2510041 · Cited by 8
“24 Thus, the present study aimed to investigate the potential effects of TAM2 on the behavior of NSCLC cells.”
Ali, E. A. M., Altaie, A. M., Talaat, I. M., & Hamoudi, R. (2025) · Cancers · doi:10.3390/cancers17172856 · Cited by 10
“M1 and M2 states represent the extremes of a diverse array of macrophage polarization states, each characterized by a unique phenotype; some express highly proangiogenic factors such as vascular endothelial growth factor-A (VEGF-A) and matrix metalloproteinases (MMPs) [12].”
Ye, Z., Yu, W., Huang, M., Chen, Y., Zhang, L., Leung, C., Zhang, X., Tang, Z.-H., Li, T., & Lu, J. (2025) · Advanced Science · doi:10.1002/advs.202508245 · Cited by 13
The metabolic regulation of tumor-associated macrophage reprogramming
Fan, H., Lu, D., Yin, X., Sun, H., Wang, Z., Sun, H., Li, Y., Li, Y., Zhou, Z., Chen, L., et al. (2025) · Molecular Immunology · doi:10.1016/j.molimm.2025.10.006 · Cited by 10
Liver microenvironment and therapy resistance in hepatocellular carcinoma
Rahi, K., Hedayati, M., Hendi, Z., Najimi, M., & Vosough, M. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104997 · Cited by 9
Modulating macrophage polarization by photobiomodulation
Ferreira, V. B., Sarmento, J. B., & de Paoli, F. (2025) · Lasers in Medical Science · doi:10.1007/s10103-025-04717-z · Cited by 34
“These M1 macrophages are predominantly pres - ent during the initial phases of inflammation and activate pro-inflammatory signalling pathways, secreting reactive oxygen and nitrogen species along with pro-inflammatory cytokines like TNF-α and IL-1 [8].”
Yang, S., Ma, Y., Wu, T., & Huang, X. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08411-y · Cited by 8
Liu, Z., Li, Y.-R., Yang, Y., Shen, X., Zhu, E., Nan, H., Wang, S., Lin, J., Yang, L., & Li, S. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100380 · Cited by 13
Castrogiovanni, P., Barbagallo, I. A., Imbesi, R., Musumeci, G., Sanfilippo, C., Broggi, G., Caltabiano, R., Tibullo, D., Giallongo, C., Forte, S., et al. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154038 · Cited by 8
Skiba, W., Suszczyk, D., Pawłowska, A., Włodarczyk, K., Pańczyszyn, A., & Wertel, I. (2022) · Cells · doi:10.3390/cells11233851 · Cited by 9
“The ratio from antitumour M1 changes to protumour M2 status [79].”
BackgroundThe Somatic Mutational Landscape and Role of ARID1A Gene in Hepatocellular Carcinoma
Meng, G.-X., Yang, C., Yan, L., Yang, Y., Yan, Y., Hong, J., Chen, Z., Dong, Z., & Li, T. (2022) · Heliyon · doi:10.1016/j.heliyon.2023.e14307 · Cited by 8
Serum resistin and the risk for hepatocellular carcinoma in diabetic patients
Abdalla, M. M. I. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i27.4271 · Cited by 8
Pawar, V. A., Tyagi, A., Verma, C., Sharma, K. P., Ansari, S., Mani, I., Srivastva, S. K., Shukla, P. K., Kumar, A., & Kumar, V. (2023) · PubMed Central · Cited by 12
Immune Features of Tumor Microenvironment: A Genetic Spotlight
Asadi, M., Zarredar, H., Zafari, V., Soleimani, Z., Saeedi, H., Caner, A., & Shanehbandi, D. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01192-7 · Cited by 11
“Usually, high macrophage existence is related with low prognosis in various kind of malignancy, like gastric, lung and breast tumor [18, 19].”
Colorectal Liver Metastasis: Can Cytokines Make the Difference?
Ballarò, C., Quaranta, V., & Giannelli, G. (2023) · Cancers · doi:10.3390/cancers15225359 · Cited by 10
“In turn, M2 cells secrete cytokines such as CCL22, CCL17, IL-10, and TGF β , which support an immunosuppressive microenvironment [42].”
BackgroundLiu, D., Wu, H., Kong, X., He, Z., Fang, Y., Li, Y., Yang, X., Ye, L., Ji, J., Xi, Y., et al. (2023) · Applied Materials Today · doi:10.1016/j.apmt.2023.102027 · Cited by 10
Peng, D., Wang, Y., Yao, Y., Yang, Z., Wu, S., Zeng, K., Hu, X., & Zhao, Y. D. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04904-y · Cited by 8
“[40, 41] Currently, macrophage polarization is classified based on the polarization spectrum doctrine consisting of two primary types of cells that can be considered as the two extremes of the polarization spectrum.”
Wang, D., Chan, B. C.-L., Zhang, B., Wong, K. C., Kan, L. L., & Wong, C. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063081 · Cited by 10
“…[78], which could not only recruit Treg cells via C-C chemokine receptor 4 (CCR4) to exacerbate the immunosuppressive condition in the cancer microenvironment [79], but also secrete anti-apoptotic cytokines such as TGF-β and epidermal growth factor (EGF) to promote tumor cell proliferation [78].”
BackgroundDai, J., Jia, J., Zhang, F., Liu, K., Xi, Y., Yuan, P., Mao, L., Bai, X. L., Wei, X., Wang, B., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0406 · Cited by 8
The role of IGFBP-3 in tumor development and progression: enlightenment for diagnosis and treatment
Wang, Y., Zhang, H., Zhang, X., Mu, P., Zhao, L., Qi, R., Zhang, Y., Zhu, X., & Dong, Y. (2024) · Medical Oncology · doi:10.1007/s12032-024-02373-x · Cited by 8
“However, in tumors, TAMs preferentially exhibit the M2-type polarization; this subtype exhibits a significant immunosuppressive activity and promotes angiogenesis, tumor growth, and metastasis [58, 59].”
Upadhyay, R., Dhakal, A., Wheeler, C. E., Hoyd, R., Singh, M. J., Karivedu, V., Bhateja, P., Bonomi, M. R., Valentin, S., Gamez, M. E., et al. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2350249 · Cited by 10
“25,26 In fact, M2 macrophages have been found to be more resistant to radiation therapy in the context of glioblastomas than M1 macrophages.”
BackgroundTargeting the Depletion of M2 Macrophages: Implication in Cancer Immunotherapy
Festekdjian, T., & Bonavida, B. (2024) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2024053580 · Cited by 8
Myeloid‑derived suppressor cells as targets of emerging therapies and nanotherapies (Review)
Kumar, D., Silva, V. D., & Chaves, N. L. (2024) · Medicine International · doi:10.3892/mi.2024.170 · Cited by 9
“Conversely, in the context of tumor development, M2 macrophages are regarded as ‘tumor promoters’. they facilitate cancer progression, promote tumor cell metastasis and angiogenesis, regulate energy metabolism and aid in immune system evasion (70).”
BackgroundBrown, N. D., & Vomhof‐DeKrey, E. E. (2024) · Cells · doi:10.3390/cells13141178 · Cited by 8
“M1 cells are derived from peripheral monocytes that polarize in accordance with cytokine and growth factor concentrations that are present within the tissue of the infiltrating monocyte [52–54].”
BackgroundInfluentialEmerging concepts of migrasome: An up‐and‐coming organelle from biology to the clinic
Jiao, L., Luo, X., Xu, Y., Sun, T., Lei, X., Song, X., & Ying, B. (2024) · The FASEB Journal · doi:10.1096/fj.202400503rr · Cited by 9
“53,54 Zhang et al. have found that pancreatic cancer cells produce migrasomes rich in CXCL5 and TGF β 1.”
Solórzano, J. L., Menéndez, V., Parra, E. R., Solis, L. M., Salazar, R., García‐Cosío, M., Climent, F., Fernández, S., Díaz, E., Francisco‐Cruz, A., et al. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2388304 · Cited by 8
Organelle Specific Macrophage Engineered Vesicles Differentially Reprogram Macrophage Polarization
Neupane, K. R., Aryal, S. P., Harvey, B. T., Ramon, G. S., Chun, B. J., McCorkle, J. R., Kolesar, J., Kekenes-Huskey, P. M., & Richards, C. I. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401906 · Cited by 10
Yuan, W., Zhang, J., Chen, H., Zhuang, Y.-P., Zhou, H., Qiu, W., Qiu, W., & Zhou, H. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-06022-8 · Cited by 9
Zhang, X., Wen, J., Pan, Z., Liu, Y., & Zhu, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113665 · Cited by 8
Wang, X., Li, L., Zhang, X., Zhang, M., Sun, Z., Yang, Y., Zhang, X., Yuan, Y., Zhang, Y., Chen, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1501009 · Cited by 9
OGT-mediated O-GlcNAcylation regulates macrophage polarization in heart failure via targeting IRF1
Jing, G., & Ma, Y. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04429-2 · Cited by 9
Chen, Q., Deng, D., Zhu, H., & Li, S. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-03654-z · Cited by 8
“Macrophages are typically polarized into pro-inflammatory M1 and anti-inflammatory M2 sub-types, each executing distinct and often opposing roles [48, 49].”
Wu, Y., Liu, M., Zhou, H.-L., He, X., Wei, J., Hua, W., Li, H.-J., Yuan, Q., & Xie, Y.-F. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i3.95092 · Cited by 11
Mathematically mapping the network of cells in the tumor microenvironment
van Santvoort, M., Lapuente-Santana, Ó., Zopoglou, M., Zackl, C., Finotello, F., van der Hoorn, P., & Eduati, F. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.100985 · Cited by 10
You, J., Shen, J., Liu, W., Zhou, J., Yu, Y., Liu, C., Wang, F., Li, A., & Qiao, J. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c06240 · Cited by 8
Tu, Y., Yang, Z., He, Y., Wang, T., Hua, P., Yao, Q., & Gu, H. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04060-x · Cited by 9
“M1 macrophages inhibit cell pro - liferation and induce tissue damage through the secretion of pro-inflammatory cytokines and nitric oxide (NO), and are induced by T-helper type 1 cell cytokines such as IFN-γ, IL-1β, and lipopolysaccharide (LPS) [ 30 ].”
Macrophage Polarization in Lung Diseases: From Mechanisms to Therapeutic Strategies
Wang, J., Niu, H., Kang, J., Liu, H., & Dong, X. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2490898 · Cited by 9
“M1 macrophages, driven by stimuli such as IFN-γ, exhibit anti-tumoral properties by producing cytokines like TNF-α and IL-12, enhancing immune responses and mediate cytotoxicity to kill tumor cells (Boutilier & Elsawa, 2021).”
Targeting Lineage-Specific Functions of NR4A1 for Cancer Immunotherapy
Kleberg, J., Nataraj, A., Xiao, Y., Podder, B. R., Jin, Z., Tithi, T. I., Zheng, G., Smalley, K. S. M., Moser, E. K., Safe, S. H., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115266 · Cited by 8
“Studies have shown that M1-like and M2-like macrophages have opposing effects within the TME [58].”
Glycolytic reprogramming in macrophage polarization: New horizons in the treatment of tumor diseases
Wang, D., & Guan, H. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111940 · Cited by 10
Liang, K., Xu, L., Ta, Y., Wang, R., Ma, S., Xiao, C., Zhang, X., Gao, Y., & Li, M. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106721 · Cited by 9
Expanding Immunotherapy Beyond CAR T Cells: Engineering Diverse Immune Cells to Target Solid Tumors
Andreou, T., Neophytou, C., Mpekris, F., & Stylianopoulos, T. (2025) · Cancers · doi:10.3390/cancers17172917 · Cited by 8
“…the full clinical potential of CAR Ms. Limited identification of tumor-specific or tumor-Cancers associated antigens (TSAs/TAAs) constrains targeting scope and heightens the risk of on-target, off-tumor toxicity, while antigen escape remains a shared limitation with CAR T therapy [174,184,185].”
Dong, K., Liu, J., Zhou, W., & Zhang, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.930248 · Cited by 8
“Tumor-associated macrophages can also perform pre-tumor activities such as enhancing tumor cell proliferation, and invasion, angiogenesis, and inhibiting anti-tumor immune surveillance (Chen et al., 2021b; Boutilier and Elsawa, 2021).”
BackgroundXu, S., Gao, X., Qiu, J., Hong, F., Gao, F., Wang, X., & Zhang, S. (2023) · Aging · doi:10.18632/aging.204529 · Cited by 9
Huang, X., Xie, X., Kang, N., Qi, R., Zhou, X., Wang, Y., & Jiang, H. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101757 · Cited by 13
“M1 macrophages are characterized by antitumor effects and produce proinflammatory factors, whereas M2 macrophages are antiinflammatory and exert protumor effect, and their polarization state is not fixed and can be altered based on various signals [23].”
BackgroundMol, B. A., Wasinda, J. J., Xu, Y., Gentle, N. L., & Meyer, V. (2024) · Journal of Immunological Methods · doi:10.1016/j.jim.2024.113716 · Cited by 9
Noguchi, A., Numata, Y., Sugawara, T., Miura, H., Konno, K., Adachi, Y., Yamaguchi, R., Ishida, M., Kokumai, T., Douchi, D., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-67757-5 · Cited by 8
Ortiz-Rivera, J., Albors, A., Kucheryavykh, Y. V., Harrison, J. K., & Kucheryavykh, L. Y. (2022) · Brain Sciences · doi:10.3390/brainsci12070893 · Cited by 8
“Previous studies have reported that TIM express a mixture of genes and markers in advanced glioma tumors [26,27], which reflect two types of inflammation: T helper (Th1)-related type I inflammation leading to natural killer (NK) cell”
BackgroundZhou, J., Luo, W., Xie, Z., Xia, C., & Zhao, J. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23816 · Cited by 7
P2 purinergic receptor expression and function in tumor-related immune cells
Manoharan, V., Adegbayi, O. O., & Maynard, J. P. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10054-7 · Cited by 9
“M2 macrophages are characterized by reduced phagocytic activity compared to M1 macrophages and the ability to aid tumors in escaping immune killing [52–54].”
AXL/GAS6 signaling governs differentiation of tumor-associated macrophages in breast cancer
Purohit, S., Mandal, G., Biswas, S., Dalui, S., Gupta, A., Chowdhury, S. R., & Bhattacharyya, A. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114324 · Cited by 8
Zhang, L., Guo, R., Chen, M., Liu, M., Liu, Y., Yu, Y., Zang, J., Kong, L., & Li, X. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s507038 · Cited by 8
“52,53 There was an increase in M1-type macrophages treated by RC-PH-Ms, which secreted substantial amounts of tumor-inhibiting growth factors, leading to the inhibition of tumor growth and proliferation.”
Characterizing macrophage diversity in colorectal malignancies through single-cell genomics
Zhao, T., Luo, Y., Sun, Y., & Wei, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1526668 · Cited by 13
“Macrophages, crucial immune components of the TME, play a signi fi cant role in recognizing and phagocytosing pathogens as well as necrotic cells, thereby contributing to immune regulation and maintaining tissue homeostasis (14, 15).”
Peng, X., Yu, S., Xu, L., Wang, Q., Yang, L., Su, Y., Xiong, Z., Shao, M., Geng, M., Zhang, A., et al. (2025) · Molecules · doi:10.3390/molecules30102088 · Cited by 7
“…mRNA expression levels of ARG1, NOS2, the classic M2 marker CD206, and the classic M1 marker MHC II in RAW 264.7 cells stimulated with IL-4/IL-13 [34], and the results showed that compound 1 signi fi cantly reduced the mRNA expression levels of ARG1 and CD206. mRNA expression levels of ARG1,…”
InfluentialProgress of ursolic acid on the regulation of macrophage: summary and prospect
Feng, W., Yang, K., Zou, Y., Xiao, Z., Qian, R., & Qian, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1576771 · Cited by 9
“This approach facilitates rapid and high quality skin wound healing in diabetic mice (44).”
Lu, B., Huang, Q., & Zhong, Y. (2025) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70020 · Cited by 8
“23 Macrophages mainly exist in two activation states, M1 and M2.”
Zhang, S., Zhang, L., Guan, N., Xu, F., Lu, M., & Wang, Y. (2025) · Oncogene · doi:10.1038/s41388-025-03497-8 · Cited by 7
“Particularly, the M2 polarization of TAMs favors immunosuppression in the TME, providing favorable conditions for tumor development [16 – 18].”
Su, Y., Wu, H., Duan, K., Xie, J., Huang, W., Mou, X., Ye, X., Shen, Y., Li, T., He, J., et al. (2025) · Theranostics · doi:10.7150/thno.114467 · Cited by 8
“To test whether M1M@Ds could be taken up by B16F10 tumor cells, we labeled M1M@Ds with the fluorescent dye Dio, and M1M@Ds was added to B16F10 tumor cells for co-culture at 0, 2, 6, 8, 12, and 24 h, respectively.”
Thylakoids for enhanced photodynamic therapy in hypoxic tumours
Yin, T., Liu, J., Wu, Y., Peng, X., Hao, Z., Zhang, J., & Zhan, X. (2025) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2025.2537000 · Cited by 7
“Furthermore, TAMs secrete factors that drive the polarization of M2 macrophages [77].”
Yao, L., Ma, Y.-T., Liu, R., Hu, Q., Xing, Q., Li, Y., Sun, X., Cao, L., & Mu, W. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114119 · Cited by 7
Chuang, A. E.-Y., Tao, Y.-K., Fan, Y., Chiu, H.-J., Rethi, L., & Liu, C. (2025) · Nanoscale · doi:10.1039/d5nr00374a · Cited by 7
M1 macrophages enhance breast cancer chemoresistance via JAK-STAT3 signaling
Feng, Y., Chen, F., Mu, C., Wang, L., Jiang, Y., Liu, D., Li, D., Chen, L., Zhai, Y., Yang, T., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168056 · Cited by 8
Li, X., Zhu, M., & Dong, R. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1643235 · Cited by 11
“…responses and tumorigenesis within the TME, with M1 macrophages primarily involved in pro-in fl ammatory responses and historically viewed as antitumor cells, while M2 macrophages were predominantly associated with anti-in fl ammatory responses and contribute to pro-tumorigenic outcomes (34).”
Fang, Y., Chen, Y., Yu, X., Zhang, J., Zhu, W., Mou, C., Wang, D., Chen, A., Zhang, R., Liu, Q., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04822-4 · Cited by 7
“* p 0.05, ** p 0.01, *** p 0.001, ns, not significant macrophage populations to decrease the harmful effects of M1-secreted inflammatory mediators in the intestinal tract [51].”
InfluentialTrojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment
Wang, W., Mu, S., Zhang, J., Shan, G., Li, X., Wang, R., Guo, T., & He, X. (2026) · Advanced Science · doi:10.1002/advs.202519213 · Cited by 9
“However, TME macrophages can also enhance tumor proliferation, angiogenesis, metastasis, and inhibit CD8 + T cell recruitment/activation [ 31, 32 ].”
Metadata
- Authors
- Boutilier, A. J., & Elsawa, S. F.
- Affiliations
- University of New Hampshire (US)
- Corresponding author
- Elsawa, Sherine F.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-29
- Volume
- 22
- Issue
- 13
- Pages
- 6995
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8268869
- OpenAlex
- W3173665490
- Cited by
- 1,631
- References
- 148
- Citations by year
- 2026: 281 · 2025: 409 · 2024: 429 · 2023: 359 · 2022: 144 · 2021: 9
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (P20 GM113131)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- macrophage polarization, tumor-associated macrophages, tumor microenvironment, tumor progression, angiogenesis, lymphangiogenesis, immunosuppression, hypoxia, metastasis, macrophage recruitment
- MeSH terms
- Tumor-Associated Macrophages, Animals, Hypoxia, Cell Transformation, Neoplastic, Humans, Inflammation, Macrophage Activation, Neoplasm Metastasis, Neoplasm Staging, Signal Transduction, Biomarkers, Immunophenotyping, Cytokines, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.